MTD Mettler Toledo

Q3 2025 10-Q

Filed: Nov 7, 2025Period ending Sep 30, 2025

Health Care

Laboratory Analytical InstrumentsSEC EDGAR

Mettler Toledo (MTD) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 7, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Revenue $1.03B for Q3 2025, up 8% YoY from $954.5M; nine-month revenue $2.9B, up 2% YoY from $2.83B
• Gross margin decreased to 59.2% vs 60.0% YoY for Q3; nine-month gross margin 59.2% vs 59.6% YoY

+3 more insights

Risk Factors

• No new or changed risk factors for Q3 2025 from 2024 10-K disclosures

Quarterly Financial Summary
XBRL

Revenue

$2.9B

▲ +201.7% YoY▲ +194.6% QoQ

Net Income

$583M

▲ +138.2% YoY▲ +188.3% QoQ

Net Margin

20.1%

▼ -536bp YoY▼ -44bp QoQ

Source: XBRL data from Mettler Toledo Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Mettler Toledo Quarterly Reports

Q2 2025 10-Q

Q1 2025 10-Q

Get deeper insights on Mettler Toledo

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.